Take a look at our current open trials by type.

Our studies help evaluate new medications, devices, and therapies aimed at improving everyday life for people managing these conditions.

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)

A Phase 1 Study to Evaluate the Safety and Tolerability of BEL512 in Healthy Participants and Participants With Mild-to-Moderate Asthma

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype (PERSEPHONE)

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

These conditions are underdiagnosed and misunderstood — your participation helps bring clarity and better care to thousands.

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ORX142 in Participants with Narcolepsy and Idiopathic Hypersomnia

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

A Study of TAK-360 in Adults With Idiopathic Hypersomnia